Centene (CNC) concentration risks

The company's concentration profile is primarily product-driven, with a meaningful overlay of individual state-contract dependency at the margin. The Medicaid segment is the largest single revenue block, accounting for 57% of total external revenues — a high-share structural exposure. That dominance reflects a deliberate positioning in government-sponsored health coverage rather than reliance on any single customer, so it behaves more like a market-structure tilt than an idiosyncratic risk. Still, Medicaid's exposure to federal and state funding decisions, enrollment policy, and rate-setting makes it the primary macro lever on the income statement. Layered on top of the product concentration are two state-contract dependencies, each carrying a low disclosed size: both the Florida and New York Medicaid contracts individually accounted for approximately 10% or more of consolidated Medicaid premium revenues. Because the pct field shows these as thresholds rather than precise figures, the exact shares are not citable; both are described qualitatively by the filing as individually material. Loss or adverse repricing of either contract would have an outsized impact relative to the low share band they occupy at the enterprise level, given their weight within the already concentrated Medicaid segment. Net, the profile is coherent: high product concentration in a structurally stable but policy-sensitive program, with low-share individual state dependencies that compound the policy risk at a sub-segment level.

For the engine’s reasoning on CNC’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.